MENU
+Compare
BBC
ETF ticker: NYSE ARCA
AS OF
Apr 1 closing price
Price
$16.53
Change
-$1.01 (-5.76%)
Net Assets
7.92M

BBC stock forecast, quote, news & analysis

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index... Show more

Category: #Health
BBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Ad is loading...
A.I.Advisor
a Summary for BBC with price predictions
Mar 31, 2025

BBC in -8.02% downward trend, sliding for three consecutive days on March 31, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where BBC declined for three days, in of 281 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on March 25, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on BBC as a result. In of 80 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

The Moving Average Convergence Divergence Histogram (MACD) for BBC turned negative on March 28, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at .

The Aroon Indicator for BBC entered a downward trend on March 31, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for BBC's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 2 days, which means it's wise to expect a price bounce in the near future.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where BBC advanced for three days, in of 295 cases, the price rose further within the following month. The odds of a continued upward trend are .

BBC may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Arrowhead Pharmaceuticals (NASDAQ:ARWR), Novavax (NASDAQ:NVAX).

Industry description

The investment seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index. Under normal market conditions, the fund will invest not less than 80% of its assets in component securities of the index. The index seeks to track the performance of the common stock of U.S. exchange-listed biotechnology companies with a primary product offering ("lead drug") that is typically in a Phase 1, Phase 2 or Phase 3 clinical trial stage of development, but prior to receiving marketing approval.

Market Cap

The average market capitalization across the Virtus LifeSci Biotech Clinical Trls ETF ETF is 1.61B. The market cap for tickers in the group ranges from 19.57M to 13.87B. SMMT holds the highest valuation in this group at 13.87B. The lowest valued company is ALLK at 19.57M.

High and low price notable news

The average weekly price growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was 36%. For the same ETF, the average monthly price growth was 51%, and the average quarterly price growth was 325%. SLNO experienced the highest price growth at 43%, while PCVX experienced the biggest fall at -49%.

Volume

The average weekly volume growth across all stocks in the Virtus LifeSci Biotech Clinical Trls ETF ETF was 73%. For the same stocks of the ETF, the average monthly volume growth was -8% and the average quarterly volume growth was 112%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 58
P/E Growth Rating: 82
Price Growth Rating: 75
SMR Rating: 94
Profit Risk Rating: 90
Seasonality Score: 8 (-100 ... +100)
View a ticker or compare two or three
BBC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published General Information

General Information

Category Health

Profile
Fundamentals
Details
Category
Health
Address
501 Madison Avenue, Suite 501New YorkNew York
Phone
(212) 593-4383
Web
N/A